Certificates of Correction from patentlyo.com by Dennis Crouch A substantial percentage of patents continue to pass through the post-issuance correction process that leads to a Certificate of Correction. The chart above shows the number of certificates of correction issued by ...
Share via E–mail | Twitter | Facebook
Apple and the podcast industry: a better future or no future? from ipkitten.blogspot.com If you are a podcast listener, then this blogpost is for you. And If you are not a podcast listener, you should be, so this blogpost is also for
you. As
reported on May 7th ... Share via E–mail | Twitter | Facebook
A patent to prevent the EU Referendum: An IP practitioner's Brexit dream from ipkitten.blogspot.com If only the AmeriKat had a patent
to prevent the EU referendum...A precocious, yet anonymous, Kat friend has been musing on a missed opportunity in relation to the upcoming EU referendum. Assuming that under ...
Share via E–mail | Twitter | Facebook
Common Ownership Exception to AIA § 102(a)(2) Prior Art from dunlapcodding.com Alyssa Novak
It has been more than three years since the America Invents Act (“AIA”) went into effect. By this time, you are likely familiar with what constitutes patent-defeating events, or “prior art,” under 35 ...
Share via E–mail | Twitter | Facebook
Coke defends against opposition to 'ZERO' trade marks from ipkitten.blogspot.com More than one trademark practitioner has probably asked herself how soft drink giant Coca-Cola goes about protecting its various ZERO-based trade marks. A window to this question can be found in the recent ruling of ... Share via E–mail | Twitter | Facebook
Court Finds BU Delay OK in LED Patent Infringement Suit from www.greenpatentblog.com Previous posts, e.g., here and here, reported on Boston University’s LED patent enforcement activity. A recent decision handed down by a Massachusetts federal court hearing infringement lawsuits against Epistar and Everlight Electronics made ...
Share via E–mail | Twitter | Facebook
Amicus Briefs in Support of Sequenom's Petition for Certiorari: Eli Lilly and Company et al. from www.patentdocs.org By Donald Zuhn -- In March, following the Federal Circuit's denial of Sequenom's petition for rehearing en banc, Sequenom filed a petition for certiorari for Supreme Court review of the Federal Circuit's decision ...
Share via E–mail | Twitter | Facebook
European Council Conclusions On Steps To Combat Antimicrobial Resistance from www.ip-watch.org The 28 European Union member governments have concluded next steps for addressing antimicrobial resistance, with a strong emphasis on reducing use of antibiotics in animals, but also including a call for new business models.
Share via E–mail | Twitter | Facebook
WIPO GI System To Become More Expensive For Users; US Questions Administration from www.ip-watch.org Last year, amid protests from some World Intellectual Property Organization members, a new treaty was adopted to protect geographical indications, broadening an existing treaty. One of the objections of some was that the existing treaty ...
Share via E–mail | Twitter | Facebook
WHO/PAHO New Response Plan For Zika Until December 2017 from www.ip-watch.org A new response plan for a strategic response to the Zika virus has been announced by the World Health Organization and the Pan American Health Organization. The revised Zika Strategic Response Plan includes elements such ...
Share via E–mail | Twitter | Facebook
The Register slams the Financial Times over patents: "Maybe the FT's editor needs to get his story straight." from ipbiz.blogspot.com From the post at The Register
In a separate piece last week ("Brexit vote would harm EU unitary patent plans"), the FT reported that: "The long-awaited single European patent, protecting inventions through out the EU ... Share via E–mail | Twitter | Facebook
European Council Approves First-Ever Analysis Of Drug Prices With Look At IP Rights from www.ip-watch.org The 28 European Union governments today were expected to give final approval to a first-ever plan to analyse medicines competition in Europe, with reference to drug prices, generics and biosimilars, and intellectual property rights. The ...
Share via E–mail | Twitter | Facebook
Attorney Fees Calculated Using In-State Rates Even Where Use of Out-of-State Counsel Created Efficiencies from docketreport.blogspot.com The court denied in part defendant's request for attorney fees under 35 U.S.C. § 285 because the forum rate rule applied. "[Defendant] argues that the exception to the forum rate rule applies because ...
Share via E–mail | Twitter | Facebook
Claims Directed to Prioritizing Events on an Electrical Power System Found Invalid as Being Directed to Patent-Ineligible Subject Matter Under 101 from allthingspros.blogspot.com Takeaway: A PTAB panel introduced a new ground of rejection sua sponte finding that the claimed subject matter was directed to patent-ineligible subject matter. The panel found that the claimed subject matter was directed to ... Share via E–mail | Twitter | Facebook
LGBT or ally in Intellectual Property? Then this is for you... from ipkitten.blogspot.com IPKat has reported a couple of times (
here and
here) on the
IP Inclusive initiative, working for diversity and inclusivity within the intellectual property industries. IP Inclusive is spearheaded by several Intellectual Property organisations (including ...
Share via E–mail | Twitter | Facebook
DTSA: Temporary Restraining Order for Former Employer from patentlyo.com by Dennis Crouch Henry Schein, Inc., v. Cook (N.D.Cal. 2016) In one of the first written decisions based upon the Defend Trade Secrets Act (DTSA), Judge Tigar has granted Schein’s motion for ...
Share via E–mail | Twitter | Facebook
CAFC affrims PTAB in In re Zhang from ipbiz.blogspot.com The CAFC made short work of "In re Zhang."
We conclude that the Board’s findings on obviousness, including that Doi does not teach away from using the non-coated yarn of Weinle, are supported by ... Share via E–mail | Twitter | Facebook
GrafTech loses at the CAFC from ipbiz.blogspot.com Related to evidentiary issues:
GrafTech’s argument suffers from two flaws.
First, GrafTech’s argument asks us to reweigh the evidence, which we may not do under the substantial evidence standard of review. See In ... Share via E–mail | Twitter | Facebook